BAKER BROS ADVISORS LLC Insider Trading $ACAD ACADIA PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).

Over the past year BAKER BROS ADVISORS LLC has been an insider in 13 companies. The total value of shares held by BAKER BROS ADVISORS LLC in these companies amounts to $914,534,008.

BAKER BROS ADVISORS LLC Director
ACADIA PHARMACEUTICALS INC
Director
ALEXION PHARMACEUTICALS, INC.
10% Owner
Atreca, Inc.
Director
BeiGene, Ltd.
10% Owner
BELLICUM PHARMACEUTICALS, INC
10% Owner
BIOCRYST PHARMACEUTICALS INC
Director
GENOMIC HEALTH INC
HOOKIPA Pharma Inc.
10% Owner, Director
IDERA PHARMACEUTICALS, INC.
Director
IGM Biosciences, Inc.
Director
INCYTE CORP
Intellia Therapeutics, Inc.
10% Owner
Invitae Corp
Director
Kiniksa Pharmaceuticals, Ltd.
Director
Kodiak Sciences Inc.
Mirati Therapeutics, Inc.
Director, 10% Owner
Neoleukin Therapeutics, Inc.
RHYTHM PHARMACEUTICALS, INC.
Director
SEATTLE GENETICS INC /WA
XOMA Corp
$ 914534008 The total value of shares held by BAKER BROS ADVISORS LLC
Insider Rank

BAKER BROS ADVISORS LLC ranks 89 out of 350,000 insiders. Go to Insider Ranking to see more.

BAKER BROS ADVISORS LLC in ACADIA PHARMACEUTICALS INC

Trading Symbol: ACAD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 3,383,621 shares
Current Value: $129,220,486
Latest Transaction: Sep 20 2019
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 37x
Sell: 4x
Shares Bought: 18,961,821
Shares Sold: 969,131
Share Difference: +17,992,690
Value Difference: -$367,392,284

Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in ACADIA PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases00022414
Value of Purchases ($)00062,500,00062,500,00062,500,000285,146,974
No. of Sales0000012
Value of Sales ($)0000000

Sentiment: All, ACAD, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, AQXP, RYTM, SGEN, XOMA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 20 2019ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP40.001,494,02559,761,00037,470,96536 M to 37.5 M (+4.15 %)
Sep 20 2019ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP40.0068,4752,739,0003,383,6213.3 M to 3.4 M (+2.07 %)
Jun 28 2019ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA25.2430,000757,20030,000
Jun 07 2019ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyJ0.0031,2290102,87671.6 K to 102.9 K (+43.59 %)
Jun 07 2019ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyJ0.0031,2290102,87671.6 K to 102.9 K (+43.59 %)
Jun 07 2019ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorSellJ0.00421,75603,315,1463.7 M to 3.3 M (-11.29 %)
Dec 04 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseJ0.011,569161,569
Dec 04 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseJ0.011,569161,569
Dec 04 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseJ0.0110,7311070
Dec 04 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyJ0.0071,647071,6470 to 71.6 K
Dec 04 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyJ0.0071,647071,6470 to 71.6 K
Dec 04 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorSellJ0.00489,97700490 K to 0 (-100.00 %)
Dec 04 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP17.0011,178,823190,039,99135,976,94024.8 M to 36 M (+45.08 %)
Dec 04 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP17.00585,8829,959,9943,736,9023.2 M to 3.7 M (+18.59 %)
Sep 24 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP19.09131,0072,501,23824,798,11724.7 M to 24.8 M (+0.53 %)
Sep 24 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP19.0914,555277,8903,151,0203.1 M to 3.2 M (+0.46 %)
Sep 24 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP19.0138,207726,35324,667,11024.6 M to 24.7 M (+0.16 %)
Sep 24 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP19.014,24580,7023,136,4653.1 M to 3.1 M (+0.14 %)
Sep 24 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP18.64920,49517,154,89724,628,90323.7 M to 24.6 M (+3.88 %)
Sep 24 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP18.64102,2671,905,9093,132,2203 M to 3.1 M (+3.38 %)
Jun 08 2018ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA17.5230,000525,60030,000
Nov 29 2017ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseM1.3839,37854,3420
Nov 29 2017ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorPayment of ExerciseF28.001,94154,348489,977491.9 K to 490 K (-0.39 %)
Nov 29 2017ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyM1.3839,37854,342491,918452.5 K to 491.9 K (+8.70 %)
Oct 16 2017ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseM1.381,426,5901,968,6940
Oct 16 2017ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorPayment of ExerciseF35.4055,4571,963,17823,708,40823.8 M to 23.7 M (-0.23 %)
Oct 16 2017ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyM1.381,426,5901,968,69423,763,86522.3 M to 23.8 M (+6.39 %)
Jun 14 2017ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA27.2530,000817,50030,000
Aug 12 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP33.001,169,87738,605,94122,337,27521.2 M to 22.3 M (+5.53 %)
Aug 12 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP33.00133,1534,394,0493,029,9532.9 M to 3 M (+4.60 %)
Jun 13 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA39.6026,5001,049,40026,500
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP28.55262,2537,486,90421,167,39820.9 M to 21.2 M (+1.25 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP28.5528,647817,8262,896,8002.9 M to 2.9 M (+1.00 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP27.8210,818300,95920,905,14520.9 M to 20.9 M (+0.05 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP27.821,18232,8832,868,1532.9 M to 2.9 M (+0.04 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP27.72318,9698,840,95920,894,32720.6 M to 20.9 M (+1.55 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP27.7234,844965,7822,866,9712.8 M to 2.9 M (+1.23 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP27.5660,5871,669,70520,575,35820.5 M to 20.6 M (+0.30 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP27.566,618182,3842,832,1272.8 M to 2.8 M (+0.23 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP26.5528,433755,02420,514,77120.5 M to 20.5 M (+0.14 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP26.553,10682,4782,825,5092.8 M to 2.8 M (+0.11 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP26.49180,1224,772,22420,486,33820.3 M to 20.5 M (+0.89 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP26.4919,676521,3042,822,4032.8 M to 2.8 M (+0.70 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP26.2913,433353,08620,306,21620.3 M to 20.3 M (+0.07 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP26.291,46738,5602,802,7272.8 M to 2.8 M (+0.05 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP25.6114,775378,34320,292,78320.3 M to 20.3 M (+0.07 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP25.611,61441,3302,801,2602.8 M to 2.8 M (+0.06 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP26.3516,057423,0572,799,6462.8 M to 2.8 M (+0.58 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP25.9837,882983,9852,783,5892.7 M to 2.8 M (+1.38 %)
Apr 01 2016ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorBuyP25.92408,60710,593,0142,745,7072.3 M to 2.7 M (+17.48 %)
Dec 15 2015ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA32.5015,000487,50015,000
Jun 17 2015ACADACADIA PHARMACEUTI ...BAKER BROS. ADVISORS LPDirectorOption ExerciseA39.0612,500488,25012,500

Page:   1